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Case Report
IntRoductIon
Pentazocine was initially introduced in 1967 as a synthetic 
mixed agonist–antagonist, potent nonnarcotic, nonaddictive 
analgesic opioid. However, by 1969, its addictive potential 
was recognized.[1]
The addictive nature of pentazocine has led to its opioid 
use disorder which occurred more among middle-aged, 
married men.[2-5] Moreover, majority of those affected were 
health workers.[2,3] High doses of pentazocine were usually 
administered by over two-third of most of these patients, 
whereas a fifth used more than the 360 mg/day recommended 
daily dose for adults.[2,3] Studies have further documented that 
these patients did not only use pentazocine, but they were 
multiple psychoactive substance users.[2,4]
The etiology of pentazocine abuse has been linked to chronic 
painful medical conditions.[2,4] To relieve the pain from these 
medical conditions, patients have sought different routes of 
administration, for example, “blind dating” (a desperate attempt 
at injecting in an area with the preknowledge of the injection 
probably missing the vein), skin popping (subcutaneous 
injection), and mainlining which is a desperate attempt at 
intravenous route.[6]
The exact pathogenesis of the cutaneous complications of 
chronic pentazocine use is not well known. However, it 
has been suggested that the alkaline pH of the extracellular 
fluid could precipitate crystals of pentazocine if not rapidly 
absorbed, causing inflammatory reactions which led to 
abscesses and ulcers.[1] Another school of thoughts explains 
that the vasoconstrictive and vaso-occlusive properties of 
pentazocine may lead to ischemia and eventual necrosis of 
tissue around the injection site.[7]
The chronic use through these routes of administration is 
associated with several complications. These vary mostly from 
cutaneous tissue damage from repeated injections, leading to 
pentazocine sclerosis, punched-out, irregularly shaped ulcers, 
fibrosis, difficulty in venous accesses, and calcifications of 
the muscles.[4,5] Other less reported complications are deep 
vein thrombosis, toxic epidermal necrolysis, ischemia, skin 
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necrosis, contractures, gangrene, or autoamputation and 
generalized erythematous desquamation rash with altered 
follicle histopathology.[8]
This report is aimed at bringing to fore the need for standard 
and strict prescription procedure adherence by health workers, 
especially for medicines that are potentially addictive for 
patients with physical conditions.
 case hIstoRy
A middle aged, separated laboratory scientist, presented at 
the emergency unit of the hospital with a 10-year history of 
pentazocine use.  He commenced the use through prescribed 
intramuscular pentazocine 30mg b.d for two days in 2003 
following rectal haemorrhoidectomy. This relieved the 
surgery pain and gave him some euphoric effect which he 
enjoyed. Within a period of 2 years, he increased use to an 
average of 150mg TDS and sometimes exceed 600mg/day 
without prescription. However, on reaching an excess of 
600 mg/day, he experienced restlessness and drowsiness. Out 
of desperation, sometimes, he would travel several kilometers 
to buy the medication without a prescription. The withdrawal 
symptoms he experienced were sad mood, muscle aches, 
excessive yawning, and sweating. His social and occupational 
functioning was affected negatively by his inability to control 
his use of psychoactive substances. Despite the hypertrophic 
scars on his hands/legs and several abscesses which resulted 
in ulcers from the repeated injection sites, he continued the use 
of the substances for years. The routes of administration of the 
drug were frequently intravenous (“mainlining”), sometimes 
intramuscular and sparingly subcutaneous (“skin popping”). 
However, when desperate, he injected himself in the same 
area despite the awareness of the injection probably missing 
the vein (“blind dating”).
After about six years of use, the patient experienced 
intermittent sad mood, loss of interest in previously 
pleasurable activities, loss of energy, low self-esteem, and 
loss of confidence. He had pessimistic thoughts about the 
future and a high sense of guilt which further contributed to 
his continued use of pentazocine.
He claimed that he had 12-week residential treatment 
and rehabilitation programs in a tertiary mental health 
hospital twice. However, within a month of discharge on 
both occasions, he had relapsed. He has had three previous 
unsuccessful hemorrhoidectomies.
Examination of the musculoskeletal system [Figure 1] showed 
hypertrophy of the subcutaneous tissue of the right and left legs, 
both feet, subcutaneous tissue of both the lower third of the 
right and left arms, and the whole of the right and left forearms.
Right upper limb
The circumference of the upper third of the right forearm was 
46 cm, middle third of the right hand was 36 cm, lower third 
of the right leg 34 cm, and middle third of the right foot 33 cm. 
There were several depressed scars on the right arm, forearm, 
and hand [Figures 1 and 2].
Left upper and lower limb
The circumference of the middle third of the left forearm was 
42 cm, middle third of the left hand 35 cm, lower third of the 
left leg 34 cm, and middle third of the left feet 32 cm
There were multiple ulcers on the left forearm with the widest 
being 3 cm × 4 cm. The ulcers were painless and not purulent. 
There were areas of hyperpigmentation around the ulcers. The 
ulcer sites were punched out, bases were hard, and the edges 
were irregular.
A diagnosis of mental and behavioural disorder due to use of 
opioids with depressive symptoms (F11.5.54) with cooccurring 
chronic rectal haemorrhoids and lymph-oedema (International 
Classification of Disease Version 10, 1994).  
Within 48 h of admission, he was referred to a multidisciplinary 
center where he was untimely discharged due to financial 
incapability. One-year telephone follow-up revealed that the 
patient had died.
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Figure 2: The right upper showing cutaneous complications of 
pentazocine dependenceFigure 1: Cutaneous complications of the upper and lower limbs
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dIscussIon
There is a paucity of data reporting cutaneous and psychosocial 
complications of pentazocine dependence in Nigeria. Are there 
few cases of pentazocine dependence in Nigeria or is there 
under-reporting?
The age, marital status, and occupation of the patients 
comparable with previous studies.[2,3] The patient showed 
a high level of tolerance from 60 mg/day to 600 mg/day, 
and other dependence symptoms were evident through his 
desperate administration through mainlining, skin popping, 
and blind dating to relieve the withdrawal symptoms.[6]
This patient had access to pentazocine, an opioid 
analgesic over the counter contrary to the National Drug 
Policy (2003).[9] This case report also exemplifies some 
of the consequences of uncoordinated drug distribution 
in Nigeria that has been reported by the National Drug 
Distribution Guidelines (2012).[10] The high dependence 
property, unauthorized availability, and access to the drug 
are factors associated with the advanced level of morbidity 
demonstrated in this patient.
In conclusion, this case report underscores the need for proper 
and strict prescription procedures by health workers, especially 
for medicines that are potential drugs of dependence for 
patients with physical conditions. It can also serve as another 
wake-up call for better coordination of drug distribution in 
Nigeria.
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